Clinical Trial Update: A Study of TAVO101 in Atopic Dermatitis Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TAVO101 for atopic dermatitis is active but not recruiting. Sponsor: Tavotek Biotherapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• TAVO101

Snippet

Sponsor: Tavotek Biotherapeutics | Conditions: Atopic Dermatitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING